|
Re: RVX Status
|
1
|
Resverlogix Corp.
|
Nov 28, 2020 10:39AM
|
|
Re: RVX on local Calgary CTV at 5 and 6pm on 11 March
|
6
|
Resverlogix Corp.
|
Mar 12, 2021 10:26AM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 28, 2023 04:51PM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 29, 2023 06:16AM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 29, 2023 02:05PM
|
|
Re: RVX Long Covid Trial
|
1
|
Resverlogix Corp.
|
May 30, 2023 09:19AM
|
|
Re: RVX LEVEL II
|
2
|
Resverlogix Corp.
|
Aug 14, 2020 02:07PM
|
|
Re: RVX is warming up!
|
5
|
Resverlogix Corp.
|
Jan 26, 2022 09:27AM
|
|
Re: RVX End Game
|
2
|
Resverlogix Corp.
|
Jul 16, 2020 06:02AM
|
|
Re: RVX End Game
|
3
|
Resverlogix Corp.
|
Jul 16, 2020 09:17AM
|
|
Re: RVX End Game
|
3
|
Resverlogix Corp.
|
Jul 16, 2020 09:39AM
|
|
Re: RVX Current Status
|
2
|
Resverlogix Corp.
|
Feb 28, 2020 08:01AM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
2
|
Resverlogix Corp.
|
Jan 18, 2021 02:44PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
1
|
Resverlogix Corp.
|
Jan 18, 2021 04:34PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
1
|
Resverlogix Corp.
|
Jan 19, 2021 07:16AM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
3
|
Resverlogix Corp.
|
Jan 18, 2021 08:20AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 10, 2022 12:50PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
1
|
Resverlogix Corp.
|
May 09, 2022 09:26AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
7
|
Resverlogix Corp.
|
May 09, 2022 12:07PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 09, 2022 03:16PM
|
